Rubertis Francesco De - Net Worth and Insider Trading
Rubertis Francesco De Net Worth
The estimated net worth of Rubertis Francesco De is at least $211 Million dollars as of 2025-04-14. Rubertis Francesco De is the Director of Centessa Pharmaceuticals PLC and owns about 18,123,892 shares of Centessa Pharmaceuticals PLC (CNTA) stock worth over $210 Million. Rubertis Francesco De is also the Director, 10% Owner of Minerva Neurosciences Inc and owns about 561,034 shares of Minerva Neurosciences Inc (NERV) stock worth over $813,499. Details can be seen in Rubertis Francesco De's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rubertis Francesco De has not made any transactions after 2021-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rubertis Francesco De
Rubertis Francesco De Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rubertis Francesco De owns 3 companies in total, including Minerva Neurosciences Inc (NERV) , Aravive Inc (ARAV) , and Centessa Pharmaceuticals PLC (CNTA) .
Click here to see the complete history of Rubertis Francesco De’s form 4 insider trades.
Insider Ownership Summary of Rubertis Francesco De
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NERV | Minerva Neurosciences Inc | 2016-08-10 | director & 10 percent owner |
| ARAV | Aravive Inc | 2014-03-20 | director |
| CNTA | Centessa Pharmaceuticals PLC | 2021-12-02 | director |
Rubertis Francesco De Latest Holdings Summary
Rubertis Francesco De currently owns a total of 2 stocks. Among these stocks, Rubertis Francesco De owns 18,123,892 shares of Centessa Pharmaceuticals PLC (CNTA) as of December 2, 2021, with a value of $210 Million and a weighting of 99.61%. Rubertis Francesco De also owns 561,034 shares of Minerva Neurosciences Inc (NERV) as of August 10, 2016, with a value of $813,499 and a weighting of 0.39%.
Latest Holdings of Rubertis Francesco De
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals PLC | 2021-12-02 | 18,123,892 | 11.57 | 209,693,430 |
| NERV | Minerva Neurosciences Inc | 2016-08-10 | 561,034 | 1.45 | 813,499 |
Holding Weightings of Rubertis Francesco De
Rubertis Francesco De Form 4 Trading Tracker
According to the SEC Form 4 filings, Rubertis Francesco De has made a total of 3 transactions in Centessa Pharmaceuticals PLC (CNTA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Centessa Pharmaceuticals PLC is the acquisition of 34,326 shares on December 2, 2021, which cost Rubertis Francesco De around $440,059.
According to the SEC Form 4 filings, Rubertis Francesco De has made a total of 0 transactions in Minerva Neurosciences Inc (NERV) over the past 5 years. The most-recent trade in Minerva Neurosciences Inc is the sale of 125,000 shares on August 10, 2016, which brought Rubertis Francesco De around $10 Million.
Insider Trading History of Rubertis Francesco De
- 1
Rubertis Francesco De Trading Performance
GuruFocus tracks the stock performance after each of Rubertis Francesco De's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rubertis Francesco De is -23.6%. GuruFocus also compares Rubertis Francesco De's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rubertis Francesco De within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rubertis Francesco De's insider trading performs compared to the benchmark.
Performance of Rubertis Francesco De
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.07 | | | | | |
| Relative Return to S&P 500(%) | -10.03 | | | | | |
Rubertis Francesco De Ownership Network
Ownership Network List of Rubertis Francesco De
Ownership Network Relation of Rubertis Francesco De
Rubertis Francesco De Owned Company Details
What does Minerva Neurosciences Inc do?
Who are the key executives at Minerva Neurosciences Inc?
Rubertis Francesco De is the director & 10 percent owner of Minerva Neurosciences Inc. Other key executives at Minerva Neurosciences Inc include 10 percent owner Ag Boehringer , 10 percent owner Boehringer Ingelheim International Gmbh , and EVP and Head of R&D Remy Luthringer .
Minerva Neurosciences Inc (NERV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Minerva Neurosciences Inc (NERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Minerva Neurosciences Inc (NERV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Minerva Neurosciences Inc (NERV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Minerva Neurosciences Inc Insider Transactions
Rubertis Francesco De Mailing Address
Above is the net worth, insider trading, and ownership report for Rubertis Francesco De. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Rubertis Francesco De's mailing address is: Geneva V8 Ch-1204.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
